Inactive Instrument

Peak Pharmaceuticals, Inc. Stock Other OTC

Equities

CTCO

US70469W1062

Dynamic Chart
Retrieve Medical Advances Healthcare Documentation in Louisiana with New Software Implementation CI
Retrieve Medical Holdings, Inc. Announces Study Update Results Utilizing Retrieve Dx ? Software CI
Retrieve Medical Holdings Inc announced that it expects to receive $3 million in funding CI
Retrieve Medical, Inc. Forges Partnership with Louisiana Health System Hospitals CI
Retrieve Medical Holdings, Inc. Announces Patent for Enhancing Electronic Health Records CI
Retrieve Medical. Inc. Announces Signed Letter of Intent with Louisiana Health System Hospitals, to Immediately Begin the Implementation Phase of Their Patented Software Solution, Retrieve DX CI
Retrieve Medical Holdings, Inc. Announces Study Results Utilizing Retrieve Dx Software CI
Peak Pharmaceuticals, Inc. announced that it has received $0.3185 million in funding CI
Retrieve Medical. Inc. Announces New Contract with Healthcare Enterprise Technology Company CI
Retrieve Medical, Inc. Announce Signed Contract with Regional Medical Center CI
Peak Pharmaceuticals, Inc. announced that it expects to receive $0.3185 million in funding CI
Neil Reithinger Resigns as Sole Director of Peak Pharmaceuticals, Inc CI
Neil Reithinger Resigns as Chief Financial Officer of Peak Pharmaceuticals, Inc CI
Peak Pharmaceuticals, Inc. Announces CEO Changes CI
Retrieve Medical, Inc. acquired Peak Pharmaceuticals, Inc. for $26.3 million in a reverse merger transaction. CI
More news
Managers TitleAgeSince
Chief Executive Officer 54 16-04-05
Members of the board TitleAgeSince
Chief Executive Officer 54 16-04-05
More insiders
Peak Pharmaceuticals, Inc. is a blank check company. The Company is seeking other business lines. The Company's subsidiary is Peak BioPharma Corp. The Company neither engaged in any business nor generating any revenue.
Sector
-
More about the company